Canale-Theakston Carin 4
4 · Cidara Therapeutics, Inc. · Filed Jul 19, 2024
Insider Transaction Report
Form 4
Canale-Theakston Carin
Director
Transactions
- Award
Stock Option (right to buy)
2024-07-18+2,125→ 2,125 totalExercise: $12.64Exp: 2034-07-17→ Common Stock (2,125 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest on the earlier of (i) the first anniversary of the date of grant or (ii) the day prior to the date of the Issuer's 2025 annual meeting of stockholders.